Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Huanglong Biotech is a synthetic biology company specializing in the development and production of high-value natural products through metabolic engineering and microbial fermentation. The company focuses on bioactive ingredients such as ergothioneine and S-adenosylmethionine for applications in the pharmaceutical, nutraceutical, and cosmetic industries. By leveraging its proprietary synthetic biology platform, Huanglong Biotech aims to replace traditional extraction and chemical synthesis methods with sustainable, high-purity bio-manufacturing processes. Their research and development efforts are closely integrated with academic expertise from Nanjing Tech University to advance the commercialization of rare natural compounds. The company is positioned as a leader in the bio-based production of antioxidants and metabolic regulators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 南京黄龙生物科技.